BALA CYNWYD, Pa., May 19, 2016 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Anacor
Pharmaceuticals, Inc. ("Anacor" or "the Company") (Nasdaq-
ANAC-News) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to Pfizer, Inc. ("Pfizer").
Click here to learn more about the investigation
http://brodsky-smith.com/1075-anac-anacor-pharmaceuticals-inc.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Anacor shareholders will
receive only $99.25 in cash for each
share of Anacor stock they own. The investigation concerns whether
the Board of Anacor breached their fiduciary duties to
shareholders and whether Pfizer is underpaying for the Company. The
transaction may undervalue the Company and would result in a
substantial loss for many Anacor shareholders. For example, Anacor
stock traded at $152.25 per share on
August 4, 2015 and an analyst has set
a price target for Anacor stock at $130.00 per share.
If you own shares of Anacor stock and wish to discuss the legal
ramifications of the investigation, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L.
Brodsky, Esquire or Evan J. Smith,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
510, Bala Cynwyd, PA 19004,
by visiting
http://brodsky-smith.com/1075-anac-anacor-pharmaceuticals-inc.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-anacor-pharmaceuticals-inc--anac-300272058.html
SOURCE Brodsky & Smith, LLC